Human β-adrenergic receptor kinase nucleic acid molecule

US7829682B1 · kind B1 · utility

Assignee

• Incyte Corporation · US

Inventors

• Vicki Elliott · San Jose, US
• Reena Khare · Saratoga, US
• Thomas Richardson · Redwood City, US
• Joseph Marquis · San Jose, US
• Anita Swarnakar · San Francisco, US
• April Hafalia · Pacifica, US
• Shanya Becha · San Francisco, US
• Narinder K. Chawla-Walia · Union City, US
• Mariah Baughn · San Jose, US
• Soo Lee · Davis, US
• Uyen Tran · San Jose, US
• Henry Yue · Sunnyvale, US
• Danniel Nguyen · San Jose, US
• Michael Thornton · Oakland, US
• Rajagopal Gururajan · San Jose, US
• Ameena Gandhi · San Francisco, US
• Yan Lu · Mountain View, US
• Monique Yao · Mountain View, US
• Joana Li · Millbrae, US
• Wen Luo · San Diego, US
• Ernestine Lee · Kensington, US
• Ian Forsythe · Edmonton, CA
• Craig Ison · San Jose, US
• Amy D. Wilson · Calabasas, US
• Pei Jin · Palo Alto, US

Key dates

• Filing date: Mar 24, 2004
• Grant date: Nov 9, 2010
• Expiry date: Apr 26, 2026

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/70
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.